» Articles » PMID: 16817206

P2X(7) Receptors on Microglial Cells Mediate Injury to Cortical Neurons in Vitro

Overview
Journal Glia
Specialty Neurology
Date 2006 Jul 4
PMID 16817206
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The P2X(7) receptor has been implicated in the release of cytokines and in the induction of cell death, and is up-regulated in a transgenic mouse model of Alzheimer's disease. Using cocultures of rat cortical neurons and microglia, we show that ATP and the more potent P2X(7) agonist benzoylbenzoyl-ATP (BzATP) cause neuronal cell injury. The deleterious effects of BzATP-treated microglia were prevented by nonselective P2X antagonists (PPADS and oxidized ATP) and by the more selective P2X(7) antagonist Brilliant Blue G. Similar concentrations of BzATP caused release of superoxide and nitric oxide from isolated microglia, and neuronal cell injury was attenuated by a superoxide dismutase mimetic and by a peroxynitrite decomposition catalyst, suggesting a role for reactive oxide species. Cocultures composed of wild-type cortical neurons, and microglia from P2X(7) receptor-deficient mice failed to exhibit neuronal cell injury in the presence of BzATP, but retained sensitivity to injury when microglia were derived from genotypically matched normal (P2X(7) (+/+) mice), thereby establishing P2X(7) involvement in the injury process. P2X(7) receptor activation on microglia thus appears necessary for microglial-mediated injury of neurons, and proposes that targeting P2X(7) receptors may constitute a novel approach for the treatment of acute and chronic neurodegenerative disorders where a microglial component is evident.

Citing Articles

Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release.

Engelhardt J, Klawonn A, Dobbelstein A, Abdelrahman A, Oldenburg J, Brandenburg K ACS Pharmacol Transl Sci. 2025; 8(1):136-145.

PMID: 39816791 PMC: 11729421. DOI: 10.1021/acsptsci.4c00496.


Retinal response to systemic inflammation differs between sexes and neurons.

Rodriguez-Ramirez K, Norte-Munoz M, Lucas-Ruiz F, Gallego-Ortega A, Calzaferri F, Garcia-Bernal D Front Immunol. 2024; 15:1340013.

PMID: 38384465 PMC: 10880026. DOI: 10.3389/fimmu.2024.1340013.


Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.

Zheng H, Liu Q, Zhou S, Luo H, Zhang W Front Immunol. 2024; 15:1345625.

PMID: 38370420 PMC: 10869479. DOI: 10.3389/fimmu.2024.1345625.


P2X7 Receptor: an Emerging Target in Alzheimer's Disease.

Huang Q, Ying J, Yu W, Dong Y, Xiong H, Zhang Y Mol Neurobiol. 2023; 61(5):2866-2880.

PMID: 37940779 PMC: 11043177. DOI: 10.1007/s12035-023-03699-9.


Triggering of Major Brain Disorders by Protons and ATP: The Role of ASICs and P2X Receptors.

Cherninskyi A, Storozhuk M, Maximyuk O, Kulyk V, Krishtal O Neurosci Bull. 2022; 39(5):845-862.

PMID: 36445556 PMC: 9707125. DOI: 10.1007/s12264-022-00986-8.